Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Long-term evolution of CD4+ cell count in patients under combined antiretroviral therapy.

Pantazis N, Papastamopoulos V, Paparizos V, Metallidis S, Adamis G, Antoniadou A, Psichogiou M, Chini M, Sambatakou H, Sipsas NV, Gogos C, Chrysos G, Panagopoulos P, Katsarou O, Gikas A, Touloumi G; AMACS.

AIDS. 2019 Aug 1;33(10):1645-1655. doi: 10.1097/QAD.0000000000002248.

PMID:
31305332
2.

Identifying, linking, and treating people who inject drugs and were recently infected with HIV in the context of a network-based intervention.

Psichogiou M, Giallouros G, Pantavou K, Pavlitina E, Papadopoulou M, Williams LD, Hadjikou A, Kakalou E, Skoutelis A, Protopapas K, Antoniadou A, Boulmetis G, Paraskevis D, Hatzakis A, Friedman SR, Nikolopoulos GK.

AIDS Care. 2019 Apr 2:1-8. doi: 10.1080/09540121.2019.1601671. [Epub ahead of print]

PMID:
30939897
3.

Experiences of Stigma and Support Reported by Participants in a Network Intervention to Reduce HIV Transmission in Athens, Greece; Odessa, Ukraine; and Chicago, Illinois.

Williams LD, Korobchuk A, Pavlitina E, Nikolopoulos GK, Skaathun B, Schneider J, Kostaki EG, Smyrnov P, Vasylyeva TI, Psichogiou M, Paraskevis D, Morgan E, Hadjikou A, Downing MJ Jr, Hatzakis A, Friedman SR.

AIDS Behav. 2019 May;23(5):1210-1224. doi: 10.1007/s10461-019-02402-1.

PMID:
30680540
4.

Prevalence, Incidence, and Contributors of Subclinical Atheromatosis, Arteriosclerosis, and Arterial Hypertrophy in HIV-Infected Individuals: A Single-Center, 3-Year Prospective Study.

Psichogiou M, Kapelios CJ, Konstantonis G, Argyris A, Nasothimiou E, Papadopoulou M, Kitas G, Papaioannou TG, Daikos GL, Sfikakis PP, Protogerou AD.

Angiology. 2019 May;70(5):448-457. doi: 10.1177/0003319718801093. Epub 2018 Sep 20.

PMID:
30235944
5.

The HIV patient profile in 2013 and 2003: Results from the Greek AMACS cohort.

Pantazis N, Chini M, Antoniadou A, Sambatakou H, Skoutelis A, Gargalianos P, Kourkounti S, Gogos C, Chrysos G, Psichogiou M, Sipsas NV, Katsarou O, Panagopoulos P, Metallidis S, Touloumi G; AMACS.

PLoS One. 2018 Sep 12;13(9):e0203601. doi: 10.1371/journal.pone.0203601. eCollection 2018.

6.

Pockets of HIV Non-infection Within Highly-Infected Risk Networks in Athens, Greece.

Williams LD, Kostaki EG, Pavlitina E, Paraskevis D, Hatzakis A, Schneider J, Smyrnov P, Hadjikou A, Nikolopoulos GK, Psichogiou M, Friedman SR.

Front Microbiol. 2018 Aug 24;9:1825. doi: 10.3389/fmicb.2018.01825. eCollection 2018.

7.

Molecular Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Individuals in a Network-Based Intervention (Transmission Reduction Intervention Project): Phylogenetics Identify HIV-1-Infected Individuals With Social Links.

Kostaki EG, Nikolopoulos GK, Pavlitina E, Williams L, Magiorkinis G, Schneider J, Skaathun B, Morgan E, Psichogiou M, Daikos GL, Sypsa V, Smyrnov P, Korobchuk A, Malliori M, Hatzakis A, Friedman SR, Paraskevis D.

J Infect Dis. 2018 Jul 24;218(5):707-715. doi: 10.1093/infdis/jiy239.

PMID:
29697829
8.

Molecular investigation of HIV-1 cross-group transmissions during an outbreak among people who inject drugs (2011-2014) in Athens, Greece.

Paraskevis D, Nikolopoulos GK, Sypsa V, Psichogiou M, Pantavou K, Kostaki E, Karamitros T, Paraskeva D, Schneider J, Malliori M, Friedman SR, Des Jarlais DC, Daikos GL, Hatzakis A.

Infect Genet Evol. 2018 Aug;62:11-16. doi: 10.1016/j.meegid.2018.04.010. Epub 2018 Apr 10.

PMID:
29653216
9.

Encephalopathy in an adult with cat-scratch disease.

Samarkos M, Antoniadou V, Vaiopoulos AG, Psichogiou M.

BMJ Case Rep. 2018 Mar 5;2018. pii: bcr-2017-223647. doi: 10.1136/bcr-2017-223647.

PMID:
29507029
10.

Integrase Strand Transfer Inhibitors and the Emergence of Immune Reconstitution Inflammatory Syndrome (IRIS).

Psichogiou M, Basoulis D, Tsikala-Vafea M, Vlachos S, Kapelios CJ, Daikos GL.

Curr HIV Res. 2017;15(6):405-410. doi: 10.2174/1570162X15666171122155708.

PMID:
29173177
11.

Detailed Molecular Surveillance of the HIV-1 Outbreak Among People who Inject Drugs (PWID) in Athens During a Period of Four Years.

Kostaki E, Magiorkinis G, Psichogiou M, Flampouris A, Iliopoulos P, Papachristou E, Daikos GL, Bonovas S, Otelea D, Friedman SR, Hatzakis A, Paraskevis D.

Curr HIV Res. 2017;15(6):396-404. doi: 10.2174/1570162X15666171120104048.

PMID:
29165088
12.

Transmission Dynamics of HIV-1 Drug Resistance among Treatment-Naïve Individuals in Greece: The Added Value of Molecular Epidemiology to Public Health.

Paraskevis D, Kostaki E, Gargalianos P, Xylomenos G, Lazanas M, Chini M, Skoutelis A, Papastamopoulos V, Paraskeva D, Antoniadou A, Papadopoulos A, Psichogiou M, Daikos GL, Chrysos G, Paparizos V, Kourkounti S, Sambatakou H, Sipsas NV, Lada M, Panagopoulos P, Maltezos E, Drimis S, Hatzakis A.

Genes (Basel). 2017 Nov 13;8(11). pii: E322. doi: 10.3390/genes8110322.

13.

Molecular Tracing of the Geographical Origin of Human Immunodeficiency Virus Type 1 Infection and Patterns of Epidemic Spread Among Migrants Who Inject Drugs in Athens.

Paraskevis D, Kostaki E, Nikolopoulos GK, Sypsa V, Psichogiou M, Del Amo J, Hodges-Mameletzis I, Paraskeva D, Skoutelis A, Malliori M, Williams L, Friedman SR, Daikos GL, Hatzakis A.

Clin Infect Dis. 2017 Nov 29;65(12):2078-2084. doi: 10.1093/cid/cix717.

14.

Prevalence of drug resistance among HIV-1 treatment-naive patients in Greece during 2003-2015: Transmitted drug resistance is due to onward transmissions.

Paraskevis D, Kostaki E, Magiorkinis G, Gargalianos P, Xylomenos G, Magiorkinis E, Lazanas M, Chini M, Nikolopoulos G, Skoutelis A, Papastamopoulos V, Antoniadou A, Papadopoulos A, Psichogiou M, Daikos GL, Oikonomopoulou M, Zavitsanou A, Chrysos G, Paparizos V, Kourkounti S, Sambatakou H, Sipsas NV, Lada M, Panagopoulos P, Maltezos E, Drimis S, Hatzakis A.

Infect Genet Evol. 2017 Oct;54:183-191. doi: 10.1016/j.meegid.2017.07.003. Epub 2017 Jul 5.

PMID:
28688977
15.

Rapid Decline in HIV Incidence Among Persons Who Inject Drugs During a Fast-Track Combination Prevention Program After an HIV Outbreak in Athens.

Sypsa V, Psichogiou M, Paraskevis D, Nikolopoulos G, Tsiara C, Paraskeva D, Micha K, Malliori M, Pharris A, Wiessing L, Donoghoe M, Friedman S, Jarlais DD, Daikos G, Hatzakis A.

J Infect Dis. 2017 May 15;215(10):1496-1505. doi: 10.1093/infdis/jix100.

16.

Recent Advances in Antiretroviral Agents: Potent Integrase Inhibitors.

Psichogiou M, Poulakou G, Basoulis D, Paraskevis D, Markogiannakis A, Daikos GL.

Curr Pharm Des. 2017;23(18):2552-2567. doi: 10.2174/1381612823666170329142059. Review.

PMID:
28356041
17.

Staphylococcus aureus meningitis in a patient with mantle cell lymphoma under treatment with ibrutinib.

Diamantopoulos PT, Psichogiou M, Pantazatou A, Zervakis K, Rougala N, Giannakopoulou N, Daikos G, Viniou NA.

Ann Hematol. 2017 Jun;96(6):1049-1050. doi: 10.1007/s00277-017-2964-3. Epub 2017 Feb 28. No abstract available.

PMID:
28247056
18.

A network intervention that locates and intervenes with recently HIV-infected persons: The Transmission Reduction Intervention Project (TRIP).

Nikolopoulos GK, Pavlitina E, Muth SQ, Schneider J, Psichogiou M, Williams LD, Paraskevis D, Sypsa V, Magiorkinis G, Smyrnov P, Korobchuk A, Vasylyeva TI, Skaathun B, Malliori M, Kafetzopoulos E, Hatzakis A, Friedman SR.

Sci Rep. 2016 Dec 5;6:38100. doi: 10.1038/srep38100.

19.

Evaluation of the limiting antigen avidity EIA (LAg) in people who inject drugs in Greece.

Nikolopoulos GK, Katsoulidou A, Kantzanou M, Rokka C, Tsiara C, Sypsa V, Paraskevis D, Psichogiou M, Friedman S, Hatzakis A.

Epidemiol Infect. 2017 Jan;145(2):401-412. Epub 2016 Oct 26.

PMID:
27780490
20.

A contaminant-free assessment of Endogenous Retroviral RNA in human plasma.

Karamitros T, Paraskevis D, Hatzakis A, Psichogiou M, Elefsiniotis I, Hurst T, Geretti AM, Beloukas A, Frater J, Klenerman P, Katzourakis A, Magiorkinis G.

Sci Rep. 2016 Sep 19;6:33598. doi: 10.1038/srep33598.

21.

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.

Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DAMC, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Staneková D, Stanojevic M, Van Laethem K, Zazzi M, Zidovec Lepej S, Boucher CAB, Schmit JC, Wensing AMJ; SPREAD Program, Puchhammer-Stockl E, Sarcletti M, Schmied B, Geit M, Balluch G, Vandamme AM, Vercauteren J, Derdelinckx I, Sasse A, Bogaert M, Ceunen H, De Roo A, De Wit S, Echahidi F, Fransen K, Goffard JC, Goubau P, Goudeseune E, Yombi JC, Lacor P, Liesnard C, Moutschen M, Pierard D, Rens R, Schrooten Y, Vaira D, Vandekerckhove LPR, Van den Heuvel A, Van Der Gucht B, Van Ranst M, Van Wijngaerden E, Vandercam B, Vekemans M, Verhofstede C, Clumeck N, Van Laethem K, Beshkov D, Alexiev I, Lepej SZ, Begovac J, Kostrikis L, Demetriades I, Kousiappa I, Demetriou V, Hezka J, Linka M, Maly M, Machala L, Nielsen C, Jørgensen LB, Gerstoft J, Mathiesen L, Pedersen C, Nielsen H, Laursen A, Kvinesdal B, Liitsola K, Ristola M, Suni J, Sutinen J, Descamps D, Assoumou L, Castor G, Grude M, Flandre P, Storto A, Hamouda O, Kücherer C, Berg T, Braun P, Poggensee G, Däumer M, Eberle J, Heiken H, Kaiser R, Knechten H, Korn K, Müller H, Neifer S, Schmidt B, Walter H, Gunsenheimer-Bartmeyer B, Harrer T, Paraskevis D, Hatzakis A, Zavitsanou A, Vassilakis A, Lazanas M, Chini M, Lioni A, Sakka V, Kourkounti S, Paparizos V, Antoniadou A, Papadopoulos A, Poulakou G, Katsarolis I, Protopapas K, Chryssos G, Drimis S, Gargalianos P, Xylomenos G, Lourida G, Psichogiou M, Daikos GL, Sipsas NV, Kontos A, Gamaletsou MN, Koratzanis G, Sambatakou H, Mariolis H, Skoutelis A, Papastamopoulos V, Georgiou O, Panagopoulos P, Maltezos E, Coughlan S, De Gascun C, Byrne C, Duffy M, Bergin C, Reidy D, Farrell G, Lambert J, O'Connor E, Rochford A, Low J, Coakely P, O'Dea S, Hall W, Mor O, Levi I, Chemtob D, Grossman Z, Zazzi M, de Luca A, Balotta C, Riva C, Mussini C, Caramma I, Capetti A, Colombo MC, Rossi C, Prati F, Tramuto F, Vitale F, Ciccozzi M, Angarano G, Rezza G, Kolupajeva T, Vasins O, Griskevicius A, Lipnickiene V, Schmit JC, Struck D, Sauvageot N, Hemmer R, Arendt V, Michaux C, Staub T, Sequin-Devaux C, Wensing AMJ, Boucher CAB, van de Vijver DAMC, van Kessel A, van Bentum PHM, Brinkman K, Connell BJ, van der Ende ME, Hoepelman IM, van Kasteren M, Kuipers M, Langebeek N, Richter C, Santegoets RMWJ, Schrijnders-Gudde L, Schuurman R, van de Ven BJM, Åsjö B, Kran AB, Ormaasen V, Aavitsland P, Horban A, Stanczak JJ, Stanczak GP, Firlag-Burkacka E, Wiercinska-Drapalo A, Jablonowska E, Maolepsza E, Leszczyszyn-Pynka M, Szata W, Camacho R, Palma C, Borges F, Paixão T, Duque V, Araújo F, Otelea D, Paraschiv S, Tudor AM, Cernat R, Chiriac C, Dumitrescu F, Prisecariu LJ, Stanojevic M, Jevtovic D, Salemovic D, Stanekova D, Habekova M, Chabadová Z, Drobkova T, Bukovinova P, Shunnar A, Truska P, Poljak M, Lunar M, Babic D, Tomazic J, Vidmar L, Vovko T, Karner P, Garcia F, Paredes R, Monge S, Moreno S, Del Amo J, Asensi V, Sirvent JL, de Mendoza C, Delgado R, Gutiérrez F, Berenguer J, Garcia-Bujalance S, Stella N, de Los Santos I, Blanco JR, Dalmau D, Rivero M, Segura F, Elías MJP, Alvarez M, Chueca N, Rodríguez-Martín C, Vidal C, Palomares JC, Viciana I, Viciana P, Cordoba J, Aguilera A, Domingo P, Galindo MJ, Miralles C, Del Pozo MA, Ribera E, Iribarren JA, Ruiz L, de la Torre J, Vidal F, Clotet B, Albert J, Heidarian A, Aperia-Peipke K, Axelsson M, Mild M, Karlsson A, Sönnerborg A, Thalme A, Navér L, Bratt G, Karlsson A, Blaxhult A, Gisslén M, Svennerholm B, Bergbrant I, Björkman P, Säll C, Mellgren Å, Lindholm A, Kuylenstierna N, Montelius R, Azimi F, Johansson B, Carlsson M, Johansson E, Ljungberg B, Ekvall H, Strand A, Mäkitalo S, Öberg S, Holmblad P, Höfer M, Holmberg H, Josefson P, Ryding U.

Clin Infect Dis. 2016 Mar 1;62(5):655-663. doi: 10.1093/cid/civ963. Epub 2015 Nov 29.

22.

HBV-DNA levels predict overall mortality in HIV/HBV coinfected individuals.

Nikolopoulos GK, Paraskevis D, Psichogiou M, Hatzakis A.

J Med Virol. 2016 Mar;88(3):466-73. doi: 10.1002/jmv.24357. Epub 2015 Aug 27.

PMID:
26288334
23.

Enhanced HIV-1 surveillance using molecular epidemiology to study and monitor HIV-1 outbreaks among intravenous drug users (IDUs) in Athens and Bucharest.

Paraskevis D, Paraschiv S, Sypsa V, Nikolopoulos G, Tsiara C, Magiorkinis G, Psichogiou M, Flampouris A, Mardarescu M, Niculescu I, Batan I, Malliori M, Otelea D, Hatzakis A.

Infect Genet Evol. 2015 Oct;35:109-21. doi: 10.1016/j.meegid.2015.08.004. Epub 2015 Aug 4.

PMID:
26247720
24.

The Additive Value of Femoral Ultrasound for Subclinical Atherosclerosis Assessment in a Single Center Cohort of 962 Adults, Including High Risk Patients with Rheumatoid Arthritis, Human Immunodeficiency Virus Infection and Type 2 Diabetes Mellitus.

Protogerou AD, Fransen J, Zampeli E, Argyris AA, Aissopou E, Arida A, Konstantonis GD, Tentolouris N, Makrilakis K, Psichogiou M, Daikos G, Kitas GD, Sfikakis PP.

PLoS One. 2015 Jul 31;10(7):e0132307. doi: 10.1371/journal.pone.0132307. eCollection 2015.

25.

Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme.

Hatzakis A, Sypsa V, Paraskevis D, Nikolopoulos G, Tsiara C, Micha K, Panopoulos A, Malliori M, Psichogiou M, Pharris A, Wiessing L, van de Laar M, Donoghoe M, Heckathorn DD, Friedman SR, Des Jarlais DC.

Addiction. 2015 Sep;110(9):1453-67. doi: 10.1111/add.12999. Epub 2015 Jul 14.

26.

Treatment Modifications and Treatment-Limiting Toxicities or Side Effects: Risk Factors and Temporal Trends.

Pantazis N, Psichogiou M, Paparizos V, Gargalianos P, Chini M, Protopapas K, Sipsas NV, Panos G, Chrysos G, Sambatakou H, Katsarou O, Touloumi G; AMACS.

AIDS Res Hum Retroviruses. 2015 Jul;31(7):707-17. doi: 10.1089/AID.2015.0018. Epub 2015 Jun 10.

PMID:
25950848
27.

Patterns of drug resistance among newly diagnosed HIV-1 infected patients in Greece during the last decade: the crucial role of transmission networks.

Paraskevis D, Zavitsanou A, Magiorkinis E, Gargalianos P, Xylomenos G, Lazanas M, Chini M, Skoutelis A, Papastamopoulos V, Antoniadou A, Papadopoulos A, Psichogiou M, Daikos G, Vassilakis A, Chrysos G, Paparizos V, Kourkounti S, Sambatakou H, Kordossis T, Koratzanis G, Panagopoulos P, Maltezos E, Drimis S, Hatzakis A.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19742. doi: 10.7448/IAS.17.4.19742. eCollection 2014.

28.

Histological features of chronic hepatitis C in haemodialysis patients.

Sakellariou S, Boletis JN, Sypsa V, Psichogiou M, Tiniakos D, Delladetsima I.

Liver Int. 2014 Jul;34(6):e56-61. doi: 10.1111/liv.12413. Epub 2013 Dec 17.

PMID:
25234282
29.

Risk factors for community-associated methicillin-resistant Staphylococcus aureus colonisation in a large metropolitan area in Greece: An epidemiological study using two case definitions.

Tsiodras S, Daikos GL, Lee A, Plachouras D, Antoniadou A, Ploiarchopoulou F, Psichogiou M, Petrikkos G, Harbarth S.

J Glob Antimicrob Resist. 2014 Mar;2(1):27-33. doi: 10.1016/j.jgar.2013.10.001. Epub 2013 Oct 26.

PMID:
27873634
30.

Homelessness and Other Risk Factors for HIV Infection in the Current Outbreak Among Injection Drug Users in Athens, Greece.

Sypsa V, Paraskevis D, Malliori M, Nikolopoulos GK, Panopoulos A, Kantzanou M, Katsoulidou A, Psichogiou M, Fotiou A, Pharris A, Van De Laar M, Wiessing L, Jarlais DD, Friedman SR, Hatzakis A.

Am J Public Health. 2015 Jan;105(1):196-204.

31.

Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems.

Daikos GL, Tsaousi S, Tzouvelekis LS, Anyfantis I, Psichogiou M, Argyropoulou A, Stefanou I, Sypsa V, Miriagou V, Nepka M, Georgiadou S, Markogiannakis A, Goukos D, Skoutelis A.

Antimicrob Agents Chemother. 2014;58(4):2322-8. doi: 10.1128/AAC.02166-13. Epub 2014 Feb 10.

32.

Economic recession and emergence of an HIV-1 outbreak among drug injectors in Athens metropolitan area: a longitudinal study.

Paraskevis D, Nikolopoulos G, Fotiou A, Tsiara C, Paraskeva D, Sypsa V, Lazanas M, Gargalianos P, Psichogiou M, Skoutelis A, Wiessing L, Friedman SR, Jarlais DC, Terzidou M, Kremastinou J, Malliori M, Hatzakis A.

PLoS One. 2013 Nov 12;8(11):e78941. doi: 10.1371/journal.pone.0078941. eCollection 2013.

33.

Socially-integrated transdisciplinary HIV prevention.

Friedman SR, Downing MJ Jr, Smyrnov P, Nikolopoulos G, Schneider JA, Livak B, Magiorkinis G, Slobodianyk L, Vasylyeva TI, Paraskevis D, Psichogiou M, Sypsa V, Malliori MM, Hatzakis A.

AIDS Behav. 2014 Oct;18(10):1821-34. doi: 10.1007/s10461-013-0643-5.

34.

Confronting carbapenemase-producing Klebsiella pneumoniae.

Markogiannakis A, Tzouvelekis LS, Psichogiou M, Petinaki E, Daikos GL.

Future Microbiol. 2013 Sep;8(9):1147-61. doi: 10.2217/fmb.13.71. Review.

PMID:
24020742
35.

Activity of plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece.

Galani I, Souli M, Daikos GL, Chrysouli Z, Poulakou G, Psichogiou M, Panagea T, Argyropoulou A, Stefanou I, Plakias G, Giamarellou H, Petrikkos G.

J Chemother. 2012 Aug;24(4):191-4. doi: 10.1179/1973947812Y.0000000015.

36.

Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL.

Clin Microbiol Rev. 2012 Oct;25(4):682-707. doi: 10.1128/CMR.05035-11. Review.

37.

Effect of HIV type 1 subtype on virological and immunological response to combination antiretroviral therapy: evidence for a more rapid viral suppression for subtype A than subtype B-infected Greek individuals.

Paraskevis D, Touloumi G, Bakoyannis G, Paparizos V, Lazanas M, Gargalianos P, Chryssos G, Antoniadou A, Psichogiou M, Panos G, Katsarou O, Sambatakou H, Kordossis T, Hatzakis A; AMACS.

AIDS Res Hum Retroviruses. 2013 Mar;29(3):461-9. doi: 10.1089/AID.2012.0143. Epub 2012 Nov 6.

PMID:
23034083
38.

Molecular characteristics of community-associated methicillin-resistant Staphylococcus aureus colonizing surgical patients in Greece.

Hadjihannas L, Psichogiou M, Empel J, Kosmidis C, Goukos D, Bouzala J, Georgopoulos S, Malhotra-Kumar S, Harbarth S, Daikos GL; MOSAR-WP no. 1 and 4 study teams.

Diagn Microbiol Infect Dis. 2012 Dec;74(4):420-2. doi: 10.1016/j.diagmicrobio.2012.08.012. Epub 2012 Sep 26.

PMID:
23021063
39.

Time of acquisition of HCV infection in renal transplant recipients: a major prognostic factor for disease progression.

Delladetsima I, Psichogiou M, Sypsa V, Sakellariou S, Hatzakis A, N Boletis J.

Clin Transplant. 2013 Jan-Feb;27(1):72-9. doi: 10.1111/ctr.12012. Epub 2012 Sep 19.

PMID:
22994949
40.

Transmission dynamics of carbapenemase-producing Klebsiella pneumoniae and anticipated impact of infection control strategies in a surgical unit.

Sypsa V, Psichogiou M, Bouzala GA, Hadjihannas L, Hatzakis A, Daikos GL.

PLoS One. 2012;7(7):e41068. doi: 10.1371/journal.pone.0041068. Epub 2012 Jul 31.

41.

Tuberculosis after anti-TNF therapy: a continuous learning process.

Psichogiou M, Sfikakis PP, Kontos F, Daikos GL.

Scand J Rheumatol. 2012 Oct;41(5):401-3. doi: 10.3109/03009742.2012.676063. Epub 2012 Jul 18. No abstract available.

PMID:
22803620
42.

CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE.

Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord, Young J, Psichogiou M, Meyer L, Ayayi S, Grabar S, Raffi F, Reiss P, Gazzard B, Sharland M, Gutierrez F, Obel N, Kirk O, Miro JM, Furrer H, Castagna A, De Wit S, Muñoz J, Kjaer J, Grarup J, Chêne G, Bucher H.

PLoS Med. 2012;9(3):e1001194. doi: 10.1371/journal.pmed.1001194. Epub 2012 Mar 20.

43.

Hepatic progenitor cells in chronic hepatitis C: a phenomenon of older age and advanced liver disease.

Delladetsima J, Alexandrou P, Giaslakiotis K, Psichogiou M, Hatzis G, Sypsa V, Tiniakos D.

Virchows Arch. 2010 Oct;457(4):457-66. doi: 10.1007/s00428-010-0957-x. Epub 2010 Aug 19.

PMID:
20721577
44.

Risk factors for bloodstream infection with Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.

Daikos GL, Vryonis E, Psichogiou M, Tzouvelekis LS, Liatis S, Petrikkos P, Kosmidis C, Tassios PT, Bamias G, Skoutelis A.

J Antimicrob Chemother. 2010 Apr;65(4):784-8. doi: 10.1093/jac/dkq005. Epub 2010 Jan 27.

PMID:
20106862
45.

Public perceptions in relation to intention to receive pandemic influenza vaccination in a random population sample: evidence from a cross-sectional telephone survey.

Sypsa V, Livanios T, Psichogiou M, Malliori M, Tsiodras S, Nikolakopoulos I, Hatzakis A.

Euro Surveill. 2009 Dec 10;14(49). pii: 19437.

46.

Prevalence of different HPV types and estimation of prognostic risk factors based on the linear array HPV genotyping test.

Papachristou E, Sypsa V, Paraskevis D, Gkekas A, Politi E, Nicolaidou E, Anifantis I, Psichogiou M, Tsitsika A, Hadjivassiliou M, Petrikkos G, Katsambas A, Creatsas G, Hatzakis A.

J Med Virol. 2009 Dec;81(12):2059-65. doi: 10.1002/jmv.21639.

PMID:
19856480
47.

Prevalence and characterization of class 1 integrons in Escherichia coli of poultry and human origin.

Vasilakopoulou A, Psichogiou M, Tzouvelekis L, Tassios PT, Kosmidis C, Petrikkos G, Roma ES, Charvalos E, Passiotou M, Avlami A, Daikos GL.

Foodborne Pathog Dis. 2009 Dec;6(10):1211-8. doi: 10.1089/fpd.2009.0281.

PMID:
19735202
48.

Seroepidemiology of human herpesvirus 8 (HHV-8) infection in injecting drug users.

Zavitsanou A, Malliori M, Sypsa V, Petrodaskalaki M, Psichogiou M, Rokka C, Giannopoulos A, Kalapothaki V, Whitby D, Hatzakis A.

Epidemiol Infect. 2010 Mar;138(3):403-8. doi: 10.1017/S0950268809990628. Epub 2009 Aug 24.

PMID:
19698211
49.

The role of HIV-1 DNA as an additional marker of HIV-1 infection.

Beloukas A, Paraskevis D, Psichogiou M, Hatzakis A.

Curr HIV Res. 2009 May;7(3):255-65. Review.

PMID:
19442120
50.

Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections.

Daikos GL, Petrikkos P, Psichogiou M, Kosmidis C, Vryonis E, Skoutelis A, Georgousi K, Tzouvelekis LS, Tassios PT, Bamia C, Petrikkos G.

Antimicrob Agents Chemother. 2009 May;53(5):1868-73. doi: 10.1128/AAC.00782-08. Epub 2009 Feb 17.

Supplemental Content

Loading ...
Support Center